Olink

Olink®
Part of Thermo Fisher Scientific

Scientific publications

Discover the latest research using Olink’s panels for protein biomarker discovery through our comprehensive list of publications. Easily find relevant studies by filtering them or using the free-text search.  Access abstracts, PubMed entries, and full-text papers directly through the links provided.

Filters

PublicationDisease areaApplication areaSample typeProducts

Allergy, 2026
Rapid Human Skin Barrier Disruption by Sodium Dodecyl Sulfate and Associated Molecular Mechanisms

Li M., Babayev H., D'Avino P. et al.

Olink Target 96Dermatological DiseasesEnvironmental Health & ToxicologyPathophysiologyTissue Lysate

BMC Medicine, 2026
CardioMetAge estimates cardiometabolic aging and predicts disease outcomes

Li Y., Xu X., Zheng Y. et al.

Olink Explore 3072/384Metabolic DiseasesCVDAgingPathophysiologyPlasma

Clinical Chemistry, 2026
Tumor-Derived HAVCR1 As a Reliable Fluid Biomarker for the Diagnosis of CNS Lymphoma

Li S., Cao J., Ren J. et al.

Olink Explore 3072/384RevealOncologyOphthalmologyPatient StratificationCSFAqueous HumorVitreous

Journal of Clinical Medicine, 2026
Identification of Inflammatory Markers for the Prediction and Diagnosis of Diminished Ovarian Reserve Using Olink Targeted Proteomics

Li M., Zhang Y., Yu L. et al.

Olink Target 96ObstetricsGynecologyPatient StratificationFollicular Fluid

Diabetes, Obesity and Metabolism, 2026
Large‐Scale Plasma Proteomics Identifies Early Molecular Deviations and Improves Risk Prediction for Heart Failure Among Individuals With Obesity

Li M., He X., Hu B. et al.

Olink Explore 3072/384Metabolic DiseasesCVDPatient StratificationPlasma

BMC Medicine, 2026
Determinants of pro- and anti-inflammatory cytokine profiles across populations

Leonard S., Ghanbari M., Sowa P. et al.

Olink Target 96Wider Proteomics StudiesEpidemiologyPlasma

Frontiers in Immunology, 2026
Integrative plasma proteomics and myeloid- interferon profiling reveal an AI-validated vascular- endothelial stress signature distinguishing SLE flare from remission in an Indian cohort a discovery – phase study

Karmakar A., Mishra S., Kumar U. et al.

Olink Target 48Immunological & Inflammatory DiseasesPatient StratificationPlasma

JCI Insight, 2026
Hepatocyte hedgehog signaling controls ferroptosis to alleviate aging-related organ dysfunction

Jun J., Dutta R., Cho S. et al.

Olink Target 96HepatologyAgingPathophysiologySerum

Nature Communications, 2026
Pembrolizumab plus high-dose IL-2 in advanced clear cell renal cell carcinoma: six-year survival outcomes and molecular signatures from a phase 2 trial

Johnson J., Miller J., Hatoum F. et al.

Olink Target 96OncologyImmunotherapyPathophysiologyPlasma

The Lancet Respiratory Medicine, 2026
Comorbid diabetes disease severity and microbial changes in patients with bronchiectasis: a combined analysis of data from the EMBARC, EMBARC-India, Australian, and BE-China registries

Hull R., Liu Y., Cao Z. et al.

Olink Target 96Olink Explore 3072/384Metabolic DiseasesRespiratory DiseasesPathophysiologySerum

Hypertension, 2026
Proteomics Signatures of Chronic Kidney Disease in Hypertension

Huang Y., Chen D., Ye Z. et al.

Olink Explore 3072/384CVDNephrologyPathophysiologyPatient StratificationPlasma

Progress in Neuro-Psychopharmacology and Biological Psychiatry, 2026
Integrating multi-omics analysis to identify potential biomarkers and regulatory networks of ischemic stroke

Hou Z., Li Y., Pu L. et al.

Olink Target 96Olink Explore 3072/384CVDNeurologyPatient StratificationPlasmaSerum

Frontiers in Immunology, 2026
Large-scale proteome profiling identifies circulating biomarkers for disease activity and organ involvement in ANCA-associated vasculitides

Hellbacher E., Knight A., Hemmingsson P. et al.

Olink Target 96Immunological & Inflammatory DiseasesPatient StratificationPlasmaSerum

Nature, 2026
Mechanism of age-related accumulation of mtDNA mutations in human blood

Gupta R., Durham T., Chau G. et al.

Olink Explore 3072/384HematologyAgingPathophysiologyPlasma

Brain, Behavior, and Immunity, 2026
Childhood immunomodulatory biomarkers and risk of depression and psychosis-spectrum outcomes at age 24: longitudinal evidence from the ALSPAC birth cohort

Ghelfi L., Mongan D., Murphy J. et al.

Olink Target 96NeurologyPathophysiologyPlasma

Medicine, 2026
Causal effects of plasma protein–protein ratios on lung cancer subtypes: A proteome-wide Mendelian randomization and mediation analysis

Geng X., Xue J., Liu K. et al.

Olink Explore 3072/384OncologyPathophysiologyPlasma

JACC: Advances, 2026
Protein Biomarkers of Infertility Implicate Inflammation and Cell Growth/Remodeling Pathways

Flores M., Zhao Y., Li L. et al.

Olink Target 96Olink Explore 3072/384CVDObstetricsPathophysiologyPlasma

Frontiers in Immunology, 2026
Inhibitory impact of A1 and A2 cow’s milk on human peripheral blood mononuclear cells identifies TOM1 as a candidate anti-inflammatory mediator

Flad L., Weißer T., Liedl J. et al.

Olink Target 48Nutritional SciencePathophysiologyCell Culture Supernatant

Healthcraft Frontiers, 2026
Leakage-Safe Machine Learning and Explainable Artificial Intelligence for Baseline Proteomic Signal Prioritization in Preclinical Rheumatoid Arthritis

Donmez T., Mansour M.

Olink Explore 3072/384Immunological & Inflammatory DiseasesData SciencePlasma

Annals of Neurology, 2026
Genetic‐Proteomic Integration Identifies Predictive Plasma Proteins for Multiple Sclerosis

Ding Y., Hamitouche D., Thebault S. et al.

Olink Explore 3072/384NeurologyPatient StratificationPlasma

4037 publications